Evidence map›Paper›PMID 36179550›Full record

ArticleEBioMedicine2022

Gut dysbiosis and inflammatory blood markers precede HIV with limited changes after early seroconversion.

Jennifer A Fulcher, Fan Li, Nicole H Tobin, Sara Zabih, Julie Elliott, Jesse L Clark, Richard D'Aquila, Brian Mustanski, Michele D Kipke, Steven Shoptaw and 2 more

Open access · goldAbstract read
In one paragraph

Article in EBioMedicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. AnbioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Cannabis use, microbial diversity, andmedRxiv : the preprint server for health sciences · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Jennifer A FulcherDivision of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA; VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA. Electronic address: jfulcher@mednet.ucla.edu.
Fan LiDivision of Infectious Diseases, Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Nicole H TobinDivision of Infectious Diseases, Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Sara ZabihDivision of Infectious Diseases, Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Julie ElliottDivision of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Jesse L ClarkDivision of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Richard D'AquilaDivision of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Brian MustanskiDepartment of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Institute for Sexual and Gender Minority Health and Wellbeing, Northwestern University, Chicago, IL 60611, USA.
Michele D KipkeChildren's Hospital Los Angeles, Los Angeles, CA 90027, USA; Department of Pediatrics, Keck School of Medicine at the University of Southern California, Los Angeles, CA 90027, USA.
Steven ShoptawDepartment of Family Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Pamina M GorbachDepartment of Epidemiology, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA 90095, USA.
Grace M AldrovandiDivision of Infectious Diseases, Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
University of California, Los Angeles · USNorthwestern University · USUniversity of Southern California · US

Funding

UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Nina Thawata Harawa · 1997 to 2026
$53.5M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KITCHEN, SCOTT G · 1991 to 2018
$39.9M
Virology and Immunology Technology CoreP30AI117943 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Mohamed Abdel Mohsen · 2015 to 2026
$38.4M
The RADAR cohort study of multilevel Influences on HIV and substance useU01DA036939 · NIDA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Brian Mustanski, Michael E Newcomb · 2014 to 2026
$29.5M
Young Men of Color Who Have Sex with Men Cohort StudyU01DA036926 · NIDA · CHILDREN'S HOSPITAL OF LOS ANGELES · PI GOLDBACH, JEREMY THOMAS, KIPKE, MICHELE D. · 2015 to 2024
$23.3M
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE) U01DA036267 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GORBACH, PAMINA MAE, SHOPTAW, STEVEN J · 2013 to 2024
$20.5M
Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) Second Bridge Funding SupplementU24DA044554 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GORBACH, PAMINA MAE, SIMINSKI, SUZANNE M. · 2017 to 2022
$6.8M
Microbiome and Mucosal Immune Interactions in the Pathogenesis of HIV-1 TransmissionK08AI124979 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FULCHER, JENNIFER · 2018 to 2021
$617k
STI Screening as a Combined HIV Prevention Platform for MSM in PeruR34MH105272 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CLARK, JESSE LAWTON · 2015 to 2017
$604k
NIAID NIH HHS K08 AI124979NIAID NIH HHS P30 AI028697NIAID NIH HHS P30 AI117943NIDA NIH HHS U01 DA036267NIDA NIH HHS U01 DA036926NIDA NIH HHS U01 DA036939NIDA NIH HHS U24 DA044554NIMH NIH HHS P30 MH058107NIMH NIH HHS R34 MH105272
6 · The paper itself

Abstract

backgroundAlterations in the gut microbiome have been associated with HIV infection, but the relative impact of HIV versus other factors on the gut microbiome has been difficult to determine in cross-sectional studies.

methodsTo address this, we examined the gut microbiome, serum metabolome, and cytokines longitudinally within 27 individuals before and during acute HIV using samples collected from several ongoing cohort studies. Matched control participants (n=28) from the same cohort studies without HIV but at similar behavioral risk were used for comparison.

findingsWe identified few changes in the microbiome during acute HIV infection, but did find alterations in serum metabolites involving secondary bile acid (lithocholate sulfate, glycocholenate sulfate) and amino acid metabolism (3-methyl-2-oxovalerate, serine, cysteine, N-acetylputrescine). Greater microbiome differences, including decreased Bacteroides spp and increased Megasphaera elsdenii, were seen when comparing pre-HIV infection visits to matched at-risk controls. Those who acquired HIV also had elevated inflammatory cytokines (TNF-α, B cell activating factor, IL-8) and bioactive lipids (palmitoyl-sphingosine-phosphoethanolamide and glycerophosphoinositol) prior to HIV acquisition compared to matched controls.

interpretationLongitudinal sampling identified pre-existing microbiome differences in participants with acute HIV compared to matched control participants observed over the same period. These data highlight the importance of increasing understanding of the role of the microbiome in HIV susceptibility.

fundingThis work was supported by NIH/NIAID (K08AI124979; P30AI117943), NIH/NIDA (U01DA036267; U01DA036939; U01DA036926; U24DA044554), and NIH/NIMH (P30MH058107; R34MH105272).

Indexed as

DysbiosisHIV InfectionsB-Cell Activating FactorBile Acids and SaltsBiomarkersCross-Sectional StudiesCysteineHumansInterleukin-8LipidsLithocholic AcidSerineSeroconversionSphingosineSulfatesTumor Necrosis Factor-alphaB-Cell Activating FactorBile Acids and SaltsBiomarkersCysteineInterleukin-8LipidsLithocholic AcidSerineSphingosineSulfatesTumor Necrosis Factor-alphaCytokinesHIVHIV acquisitionMicrobiome

Identifiers

PMID36179550
PMCPMC9520213
OpenAlexW4297172758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.